AAV9-GLA gene therapy (Exegenesis Bio)

N/A

Report date: 2025/01/26 19:33:37

Base Information

Drug NameAAV9-GLA gene therapy (Exegenesis Bio)
Drug Alias NameGLA gene therapy (Exegenesis Bio)
ClassificationBiologics
Mechanisms of Actionα-Galactosidase stimulants
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExegenesis Bio Co
China Registration ClassN/A

Develop Information

Active CompaniesExegenesis Bio Co
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A